Feb 26, 2026 07:00AM
Jan 12, 2026 08:02AM
Jan 12, 2026 08:00AM
Jan 6, 2026 08:01AM
Jan 6, 2026 08:00AM
Dec 1, 2025 07:00AM
Nov 10, 2025 07:00AM Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Nov 6, 2025 06:30PM
Oct 28, 2025 04:30PM
Oct 28, 2025 04:30PM
Oct 20, 2025 08:08AM
Aug 21, 2025 08:01AM
Aug 21, 2025 08:00AM
Aug 7, 2025 07:00AM Akebia Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Aug 4, 2025 08:00AM
Jun 4, 2025 08:01AM
Jun 4, 2025 08:00AM
May 8, 2025 07:00AM
Apr 3, 2025 08:01AM
Apr 3, 2025 08:00AM
Mar 13, 2025 07:00AM Akebia Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Vafseo® (vadadustat) Commercial Launch Progress Update
Jan 13, 2025 08:06AM
Jan 13, 2025 08:00AM
Dec 3, 2024 07:00AM
Nov 14, 2024 08:00AM
Nov 7, 2024 07:00AM
Oct 22, 2024 08:03AM
Oct 22, 2024 08:00AM Akebia Therapeutics Signs Commercial Supply Contract with Leading Dialysis Organization to Enable Access to Vafseo® (vadadustat) for Patients on Dialysis
Oct 15, 2024 08:00AM
Oct 11, 2024 06:37AM
Oct 10, 2024 08:02AM
Oct 10, 2024 08:00AM
Oct 8, 2024 06:49AM
Oct 7, 2024 08:05AM
Oct 7, 2024 08:00AM Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply Contract to Enable Access to Vafseo® (vadadustat) for Patients on Dialysis
Sep 5, 2024 08:05AM
Sep 5, 2024 08:00AM
Aug 8, 2024 07:00AM
Jul 11, 2024 06:01AM
Jul 11, 2024 06:00AM
Jun 24, 2024 08:59AM
Jun 24, 2024 08:58AM Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer
May 9, 2024 07:00AM
Apr 1, 2024 11:09AM
Mar 27, 2024 08:56PM
Mar 27, 2024 08:26PM
Mar 14, 2024 04:15PM
Mar 11, 2024 05:05PM
Jan 9, 2024 08:30AM Akebia Therapeutics (AKBA) Appoints Nicholas Grund as Chief Commercial Officer
Jan 9, 2024 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All